These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 34416)
21. Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically ill patients. Thongprayoon C; Cheungpasitporn W; Akhoundi A; Ahmed AH; Kashani KB BMC Nephrol; 2014 Nov; 15():176. PubMed ID: 25398596 [TBL] [Abstract][Full Text] [Related]
22. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state. St-Onge JM; Sirois G; Gagnon MA Eur J Drug Metab Pharmacokinet; 1983; 8(4):363-72. PubMed ID: 6673973 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days. Hanhijärvi H; Elomaa I; Karlsson M; Lauren L Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):602-6. PubMed ID: 2533182 [TBL] [Abstract][Full Text] [Related]
24. Effect of sustained water diuresis on prostaglandin E2 excretion in humans. Roberts DG; Strife RJ; Gerber JG; Murphy RC; Nies AS Am J Physiol; 1985 Jun; 248(6 Pt 2):F830-4. PubMed ID: 3859226 [TBL] [Abstract][Full Text] [Related]
25. A study of the human metabolism of secbutobarbitone. Gilbert JN; Powell JW; Templeton J J Pharm Pharmacol; 1975 Dec; 27(12):923-7. PubMed ID: 2664 [TBL] [Abstract][Full Text] [Related]
26. Urinary creatinine excretion in the ICU: low excretion does not mean inadequate collection. Pesola GR; Akhavan I; Carlon GC Am J Crit Care; 1993 Nov; 2(6):462-6. PubMed ID: 8275151 [TBL] [Abstract][Full Text] [Related]
27. Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight. Waples JM; Moreb JS; Sugrue M; Belanger G; Kubilis P; Lynch JW; Gian V; Weeks F; Wingard J Bone Marrow Transplant; 1999 May; 23(9):867-73. PubMed ID: 10338040 [TBL] [Abstract][Full Text] [Related]
28. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. Peiris AN; Mueller RA; Struve MF; Smith GA; Kissebah AH J Clin Endocrinol Metab; 1987 Jan; 64(1):162-9. PubMed ID: 3536981 [TBL] [Abstract][Full Text] [Related]
29. Mass screening and confirmation of barbiturates in urine by RIA/gas chromatography. Jain NC Clin Toxicol; 1976; 9(2):221-33. PubMed ID: 939076 [TBL] [Abstract][Full Text] [Related]
30. Total and resting energy expenditure in obese women reduced to ideal body weight. Amatruda JM; Statt MC; Welle SL J Clin Invest; 1993 Sep; 92(3):1236-42. PubMed ID: 8376583 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of barbiturates in human biological fluids by direct immersion solid-phase microextraction and gas chromatography-mass spectrometry. Iwai M; Hattori H; Arinobu T; Ishii A; Kumazawa T; Noguchi H; Noguchi H; Suzuki O; Seno H J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 806(1):65-73. PubMed ID: 15149613 [TBL] [Abstract][Full Text] [Related]
32. The effect of glutamine administration on urinary ammonium excretion in normal subjects and patients with renal disease. Welbourne T; Weber M; Bank N J Clin Invest; 1972 Jul; 51(7):1852-60. PubMed ID: 4555786 [TBL] [Abstract][Full Text] [Related]
33. Weight change and body composition in patients with Parkinson's disease. Beyer PL; Palarino MY; Michalek D; Busenbark K; Koller WC J Am Diet Assoc; 1995 Sep; 95(9):979-83. PubMed ID: 7657912 [TBL] [Abstract][Full Text] [Related]
34. Relation between blood- and urine-amphetamine concentrations in impaired drivers as influenced by urinary pH and creatinine. Jones AW; Karlsson L Hum Exp Toxicol; 2005 Dec; 24(12):615-22. PubMed ID: 16408614 [TBL] [Abstract][Full Text] [Related]
35. Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency. Balasubramaniam K; Mawer GE; Pohl JE; Simons PJ Br J Pharmacol; 1972 Jun; 45(2):360-7. PubMed ID: 5048653 [TBL] [Abstract][Full Text] [Related]
36. The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone. Grove J; Toseland PA J Pharm Pharmacol; 1971 Dec; 23(12):936-40. PubMed ID: 4402019 [No Abstract] [Full Text] [Related]
37. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131 [TBL] [Abstract][Full Text] [Related]
39. [Influence of urinary pH on the detection of barbituates in the urine]. RAPIN M; POCIDALO JJ; MONSALLIER JF Pathol Biol; 1961 Sep; 9():1733-4. PubMed ID: 14490352 [No Abstract] [Full Text] [Related]
40. Muscularity and adiposity in addition to net acid excretion as predictors of 24-h urinary pH in young adults and elderly. Remer T; Berkemeyer S; Rylander R; Vormann J Eur J Clin Nutr; 2007 May; 61(5):605-9. PubMed ID: 17119545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]